Financial Statements — BGM
Balance Sheet
(in millions USD)| Metric | Q2
2025 | Q2
2024 |
|---|
| Cash & Equivalents | 9.65 | 10.35 |
| Short-term Investments | -- | 1.00 |
| Accounts Receivable | 5.52 | 0.72 |
| Inventory | 8.85 | 4.65 |
| Total Current Assets | 42.94 | 33.33 |
| Goodwill | 135.24 | -- |
| Intangible Assets | 4.59 | 3.42 |
| Total Non-current Assets* | 164.45 | 16.53 |
| Total Assets | 207.39 | 49.85 |
| Accounts Payable | 8.43 | 2.67 |
| Total Current Liabilities | 23.59 | 4.73 |
| Total Non-current Liabilities* | 0.32 | 0.20 |
| Total Liabilities | 23.90 | 4.93 |
| Retained Earnings | 3.49 | 6.26 |
| Total Stockholder Equity | 182.12 | 43.43 |
* Derived from reported values
Income Statement
(in millions USD) (except per-share rows)| Metric | Q2
2025 | Q2
2024 |
|---|
| Total Revenue | 14.31 | 12.56 |
| Cost of Revenue | 11.80 | 11.15 |
| Gross Profit | 2.51 | 1.41 |
| Research & Development | 0.53 | 0.47 |
| Selling, General & Admin | 3.77 | 1.40 |
| Total Operating Expenses | 4.75 | 2.09 |
| Operating Income | (2.24) | (0.68) |
| Pretax Income | (5.12) | 0.34 |
| Tax Provision | (4.30) | 0.01 |
| Net Income | (0.86) | 0.41 |
| Basic EPS | (0.03) | 0.01 |
| Diluted EPS | (0.03) | 0.01 |
Cash Flow Statement
(in millions USD)| Metric | Q2
2025 | Q2
2024 |
|---|
| Operating Cash Flow | (3.06) | 2.56 |
| Capital Expenditures | 1.02 | 0.79 |
| Free Cash Flow* | (4.07) | 1.77 |
| Investing Cash Flow | (3.26) | 0.73 |
| Financing Cash Flow | 7.36 | (0.49) |
* Derived from reported values
